SSY GROUP (02005) announced that its two medical device products—the Full-range C-reactive Protein (hsCRP + conventional CRP) Detection Kit (Fluorescence Immunochromatography) and the Serum Amyloid A/C-reactive Protein (SAA/CRP) Detection Kit (Fluorescence Immunochromatography)—have been granted medical device registration certificates by the Hebei Provincial Medical Products Administration in China. The Full-range C-reactive Protein Detection Kit is designed for the in vitro quantitative detection of C-reactive protein levels in human whole blood, serum, and plasma samples, and is clinically used to assist in the diagnosis of nonspecific inflammation and cardiovascular diseases. The Serum Amyloid A/C-reactive Protein Detection Kit is intended for the in vitro quantitative detection of Serum Amyloid A (SAA) and C-reactive Protein (CRP) levels in human serum, plasma, or whole blood samples, and is clinically applied to support the diagnosis of nonspecific inflammation. The successive approvals of multiple detection kits open a new growth pathway for the Group in the medical device product segment.